Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells

Blood

Volumn 88, Issue 1, 1996, Pages 319-327

  Sawada, K ^a   Ieko, M ^b   Notoya, A ^b   Tarumi, T ^b   Koizumi, K ^b   Kitayama, S ^b   Nishio, H ^b   Fukada, Y ^b   Yasukouchi, T ^b   Yamaguchi, M ^b   Katoh, S ^b   Koike, T ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOKINE; MONOCLONAL ANTIBODY; RECOMBINANT COLONY STIMULATING FACTOR 1; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; STEM CELL FACTOR;

ADULT; AGED; ARTICLE; BLAST CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 8944248817     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.1.319.319     Document Type: Article

References (44)

1. Greenberg PL, Mara B: The preleukemic syndrome. Correlation of in vitro parameters of granulopoiesis with clinical features. Am J Med 66:951, 1979
2. Greenberg PL, Mara B, Bax I, Brossel R, Schrier S: The myeloproliferative disorders: Correlation between clinical evolution and alteration of granulopoiesis. Am J Med 61:878, 1976
3. Faille A, Dresch C, Poirer O, Balitrand N, Najean Y: Prognostic value of in vitro bone marrow culture in refractory anaemia with excess of myeloblasts. Scand J Haematol 20:280, 1978
4. Berthier R, Douady F, Metral J, Newton I, Schweitzer A, Holland D: In vitro granulopoiesis in oligoblastic leukemia: Prognostic value, characterization and serial cloning of bone marrow colony and cluster forming cells in agar culture. Biomedicine 30:305, 1979
5. Spitzer G, Verma DS, Dicke KA, Smith T, McCredie KB: Subgroups of oligoleukemia as identified by in vitro agar culture. Leuk Res 3:29, 1979
6. Verma DS, Spitzer G, Dicke KA, McCredie KB: In vitro agar culture patterns in preleukemia and their clinical significance. Leuk Res 3:41, 1979
7. Pike B, Robinson WA: Human bone marrow colony growth in agar gel. J Cell Physiol 76:77, 1970
8. Wodnar-Filipowicz A, Yancik S, Moser Y, Carbonare VD, Gratwohl A, Tichelli A, Speck B, Nissen C: Levels of soluble stem cell factor in serum of patients with aplastic anemia. Blood 81:3259, 1993
9. Bowen D, Yancik S, Bennett L, Culligan D, Resser K: Serum stem cell factor concentration in patients with myelodysplastic syndromes. Br J Haematol 85:63, 1993
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189, 1982
11. + cells in serum-free medium: II. Response to combined colony-stimulating factors. Eur J Haematol 54:85, 1995
12. 4 cells. Blood 85:194, 1995
13. Sawada K, Krantz SB, Dai CH, Koury ST, Horn ST, Glick AD, Civin CI: Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors. J Cell Physiol 142:219, 1990
14. Sato N, Sawada K, Kannonji M, Tarumi T, Sakai N, Ieko M, Sakurama S, Nakagawa S, Yasukouchi T, Krantz SB: Purification of human bone marrow progenitor cells and demonstration of the direct action of macrophage colony-stimulating factor on colony-forming unit-macrophage. Blood 78:967, 1991
15. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133:157, 1984
16. Sawada K, Krantz SB, Dessypris EN, Koury ST, Sawyer ST: Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest 83:1701, 1989
17. Sawada K, Krantz SB, Dai CH, Sato N, Ieko M, Sakurama S, Yasukouchi T, Nakagawa S: Transitional change of colony stimulating factor requirements for erythroid progenitors. J Cell Physiol 149:1, 1991
18. - progenitor cells. Blood 77:1218, 1991
19. Civin CI: Human monomyeloid cell membraine antigens. Exp Hematol 18:461, 1990
20. + cells. Blood 82:3600, 1993
21. Raymakers R, De Witte T, Joziasse J, Der Lely V, Boezeman J, Haanen C: In vitro growth pattern and differentiation predict for progression of myelodysplastic syndromes to acute nonlymphocytic leukemia. Br J Haematol 78:35, 1991
22. Hanamura T, Motoyoshi K, Yoshida K, Saito M, Miura Y, Kawashima T, Nishida M, Takaku F: Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay. Blood 72:886, 1988
23. Greenberg PL: In-vitro culture techniques defining biologic abnormalities in the myelodysplastic syndromes and myeloproliferative disorders. Clin Haematol 15:973, 1986
24. Nagler A, Binet C, Mackichan ML, Negrin R, Bangs C, Donlon T, Greenberg PL: Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: Comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocyte-monocyte CSF. Blood 76:1299, 1990
25. Nagler A, Ginzton N, Negrin R, Bang D, Donlon T, Greenberg PL: Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hematopoiesis in the myelodysplastic syndromes. Leukemia 4:193, 1990
26. Golde DW, Cline MJ: Human preleukemia: Identification of a maturation defect in vitro. N Engl J Med 288:1083, 1973
27. Firkin FC, Birner R, Russell SH, Garson M: Contrasting patterns of neoplastic cell behavior in long-term culture of bone marrow from patients with acute leukaemia and myelodysplastic disorders. Br J Haematol 75:476, 1990
28. Schipperus M, Sonneveld P, Lindemans J, Hagemeijer A, Vink N, Pegels J, Abels J: The effects of interleukin-3, GM-CSF, and G-CSF on the growth kinetics of colony-forming cells in myelodysplastic syndromes. Leukemia 4:267, 1990
29. + cells in serum-free medium: Response to individual colony-stimulating factors. Br J Haematol 83:249, 1993
30. Merchav S, Wagemarker G, Souza LM, Tatarsky I: Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant hematopoietic growth factors. Leukemia 5:340, 1991
31. Mayani H, Baines P, Bowen DT, Jacobs A: In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia 3:29, 1989
32. Thomas X, Guyotat D, Campos L, Shi ZH, Vila L, Ehrsam A, Fiere D: In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes. Leuk Res 15:29, 1991
33. Tohyama K, Ohmori S, Michishita M, Ueda Y, Sakoda H, Yoshida Y, Uvhino H: Effects of recombinant G-CSF and GM-CSF on in vitro differentiation of the blast cells of RAEB and RAEB-T. Eur J Haematol 42:348, 1989
34. Carlo-Stella C, Cazzola M, Bergamaschi G, Dezza L, Invernizzi R, Pedrazzoli P: Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia 3:363, 1989
35. McNiece IK, Langley KE, Zsebo KM: Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells in the myeloid and erythroid lineages. Exp Hematol 19:226, 1991
36. Broxmeyer HE, Cooper S, Lu L, Hangoc G, Anderson D, Cosman D, Lyman SD, Williams DE: Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood 77:2142, 1991
37. Backx B, Breeders L, Löwenberg B: Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome. Blood 80:1213, 1992
38. Maze R, Hone M, Hendrie P, Vadhan-Raj S, Tricot G, Gordon M, Nemunaitis J, Ashman LK, Broxmeyer HE: Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Exp Hematol 21:545, 1993
39. Piacibello W, Sanavio F, Bresso P, Severino A, Carlesso N, Pregno P, Stacchini A, Morelli S, Fubini L, Gallo E, Aglietta M, Ferrero D: Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes. Leukemia 8:250, 1994
40. Soligo D, Servida F, Cortelezzi A, Pedretti D, Morgutt M, Pogliani E, Lambertenghi Deliliers G: Effects of recombinant human stem cell factor (rh-SCF) on colony formation and long-term bone marrow cultures (LTBMC) in patients with myelodysplastic syndromes. Eur J Haematol 52:53, 1994
41. Asano H, Hotta T, Ichihara M, Murata T, Kobayashi M, Saito H: Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes. Leukemia 8:833, 1994
42. Wu HK, Chiba S, Hirai H, Takaku F, Yazaki Y: Effect of stem cell factor (c-kit ligand) on clonogenic leukemia precursor cells: Synergy with other hematopoietic growth factors. Am J Hematol 47:328, 1994
43. Glinsmann-Gibson B, Spier C, Baier M, Taetle R, Broudy VC, List AF: Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome. Leukemia 8:827, 1994
44. Tohyama K, Ueda T, Yoshida Y, Nakamura T: Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro: Comparison with normal blast cells. Exp Hematol 22:539, 1994